GBM tumors within the ERK1/2 cluster expressed even higher levels of CCL2/MCP1 mRNA compared with other clusters (P=0.039, Wilcoxon–Mann–Whitney) (Figure 3B). The gene discussed is CCL2; the disease is glioblastoma.